Ionis Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2024
Total Assets: $3.00B
Liabilities Breakdown FY2024
Total Liabilities: $2.42B
Asset Breakdown
Total Assets: $3.00B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $242.1M | 8.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $12.5M | 0.4% |
| Property, Plant & Equipment | $94.3M | 3.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $2.65B | 88.4% |
Liabilities Breakdown
Total Liabilities: $2.42B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $43.0M | 1.8% |
| Long-Term Debt | $1.20B | 49.8% |
| Other Liabilities | $1.17B | 48.4% |